<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6161873</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0204710</article-id><article-id pub-id-type="publisher-id">PONE-D-18-21816</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Species Interactions</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Species Interactions</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Insect Vectors</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Eukaryota</subject><subj-group><subject>Animals</subject><subj-group><subject>Invertebrates</subject><subj-group><subject>Arthropoda</subject><subj-group><subject>Insects</subject><subj-group><subject>Mosquitoes</subject><subj-group><subject>Aedes Aegypti</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>North America</subject><subj-group><subject>Caribbean</subject><subj-group><subject>Guadeloupe</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Saliva</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>North America</subject><subj-group><subject>Caribbean</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Viral Vectors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Species Interactions</subject><subj-group><subject>Disease Vectors</subject><subj-group><subject>Viral Vectors</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Transmission and Infection</subject><subj-group><subject>Viral Vectors</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>South America</subject><subj-group><subject>Brazil</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Vector-Borne Diseases</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="82531" pm="."><plain>Aedes aegypti mosquitoes from Guadeloupe (French West Indies) are able to transmit yellow fever virus </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head"><italic>Aedes aegypti</italic> and yellow fever in the Caribbean</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2113-7394</contrib-id><name><surname>Yen</surname><given-names>Pei-Shi</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Writing – original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Amraoui</surname><given-names>Fadila</given-names></name><role content-type="http://credit.casrai.org/">Investigation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vega Rúa</surname><given-names>Anubis</given-names></name><role content-type="http://credit.casrai.org/">Resources</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Failloux</surname><given-names>Anna-Bella</given-names></name><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Institut Pasteur, Department of Virology, Unit of Arboviruses and Insect Vectors, Paris, France</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Institut Pasteur de Guadeloupe, Environment and Health Unit, Laboratory of Vector Control Research, Les Abymes, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Moreira</surname><given-names>Luciano Andrade</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Centro de Pesquisas René Rachou, BRAZIL</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><text><SENT sid="82532" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><corresp id="cor001">* E-mail: <email>pei-shi.yen@pasteur.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>9</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>9</issue><elocation-id>e0204710</elocation-id><history><date date-type="received"><day>23</day><month>7</month><year>2018</year></date><date date-type="accepted"><day>12</day><month>9</month><year>2018</year></date></history><permissions><copyright-statement>© 2018 Yen et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Yen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0204710.pdf"/><abstract><p><SecTag type="ABS"><text><SENT sid="82533" pm="."><plain>The recent yellow fever epidemic in Brazil has raised the concern of outbreaks in neighboring countries, particularly in the Caribbean region where the vector Aedes aegypti is predominant. </plain></SENT>
<SENT sid="82534" pm="."><plain>This threat comes from the past when in the Americas, this disease caused devastating urban epidemics. </plain></SENT>
<SENT sid="82535" pm="."><plain>We report the vector competence of Ae. aegypti from Guadeloupe for yellow fever virus by determining different parameters describing virus infection, dissemination, and transmission. </plain></SENT>
<SENT sid="82536" pm="."><plain>The results indicate that Ae. aegypti Guadeloupe are susceptible to yellow fever virus with viral particles detected in mosquito saliva at 14 and 21 days post-infection. </plain></SENT>
<SENT sid="82537" pm="."><plain>Local authorities and more broadly, international organizations should maintain the active surveillance of Aedes mosquitoes and the spreading of human cases from South America. </plain></SENT>
</text></SecTag></p></abstract><funding-group><award-group id="award001"><funding-source><institution>French Government's investissement d'Avenir Program</institution></funding-source><award-id>ANR-10-LABX-62IBEID</award-id><principal-award-recipient><name><surname>Failloux</surname><given-names>Anna-Bella</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution>Programme Opérationnel FEDER-Guadeloupe-Conseil Régional 2014-2020</institution></funding-source><award-id>2015-FED-192</award-id><principal-award-recipient><name><surname>Rúa</surname><given-names>Anubis Vega</given-names></name></principal-award-recipient></award-group><award-group id="award003"><funding-source><institution>Institut Pasteur and the National Health Research Institutes</institution></funding-source><award-id>S-CR18039</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2113-7394</contrib-id><name><surname>Yen</surname><given-names>Pei-Shi</given-names></name></principal-award-recipient></award-group><funding-statement>ABF was funded by French Government’s Investissement d’Avenir program, Laboratoire d’Excellence “Integrative Biology of Emerging Infectious Diseases” (grant n°ANR-10-LABX-62-IBEID); AVR was funded by FEDER grant that financed by the European Union and Guadeloupe Region, Programme Opérationnel FEDER-Guadeloupe-Conseil Régional 2014-2020 (Grant number 2015-FED-192). P-SY was supported by the Institut Pasteur and the National Health Research Institutes in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="1"/><page-count count="8"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the manuscript.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the manuscript.</p></notes></front><body><SecTag type="INTRO"><sec sec-type="intro" id="sec001"><title><text><SENT sid="82538" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="82539" pm="."><plain>Yellow fever (YF) is a mosquito-borne viral disease endemic to some countries of South America and sub-Saharan Africa. </plain></SENT>
<SENT sid="82540" pm="."><plain>It can present various clinical features ranging from a self-limited, mild febrile illness to fatal symptoms such as hemorrhages and liver damages. </plain></SENT>
<SENT sid="82541" pm="."><plain>Most of all cases reported annually (80–90%) occur in Africa where YF covers 44 countries [1]. </plain></SENT>
<SENT sid="82542" pm="."><plain>In South America, YF is described in less than 10 countries: Argentina, Bolivia, Brazil, Colombia, Ecuador, Paraguay, Peru, and Venezuela (<ext-link ext-link-type="uri" xlink:href="http://ais.paho.org/phip/viz/ed_yellowfever.asp">http://ais.paho.org/phip/viz/ed_yellowfever.asp</ext-link>). </plain></SENT>
<SENT sid="82543" pm="."><plain>In these locations, YF uses to periodically spread via epizootic outbreaks following the displacements of non-human primates [2]. </plain></SENT>
<SENT sid="82544" pm="."><plain>From July 2017 through March 2018, the states of Rio de Janeiro, Minas Gerais, and São Paulo in Brazil, counted 932 human cases including 300 fatal cases [3]. </plain></SENT>
<SENT sid="82545" pm="."><plain>Alarmingly, human cases were reported near São Paulo city, threatening the initiation of an urban transmission that has not been notified in the country since 1942. </plain></SENT>
</text></p><p><text><SENT sid="82546" pm="."><plain>Originally from Africa, YF is believed to be introduced into America via the slave trade in the middle of 18th century [4]. </plain></SENT>
<SENT sid="82547" pm="."><plain>Approximately 10.7 million slaves were deported to the Caribbean, North and South Americas during four centuries [5]. </plain></SENT>
<SENT sid="82548" pm="."><plain>Likewise, the mosquito Ae. aegypti by finding suitable breeding sites in slave transport ships, was introduced in America at the same period [6]. </plain></SENT>
<SENT sid="82549" pm="."><plain>Deadly YF epidemics devastated the continent for centuries. </plain></SENT>
<SENT sid="82550" pm="."><plain>An eradication campaign targeting Ae. aegypti organized by the Pan American Health Organisation (PAHO) was initiated in 1946 and led to the elimination of the vector from most American countries, and consequently, the disappearance of urban YF [7]. </plain></SENT>
<SENT sid="82551" pm="."><plain>Unfortunately, the eradication campaign was interrupted and most countries were re-infested by the vector [8]. </plain></SENT>
</text></p><p><text><SENT sid="82552" pm="."><plain>Yellow fever virus (YFV; Flavivirus, Flaviviridae) is primarily transmitted by the mosquitoes Aedes spp. </plain></SENT>
<SENT sid="82553" pm="."><plain>(e.g. Aedes africanus) in Africa and Haemagogus (e.g. Haemagogus janthinomys) in South America [9]. </plain></SENT>
<SENT sid="82554" pm="."><plain>In Brazil, the anthropophilic mosquitoes Ae. aegypti and Aedes albopictus as well as the YFV-enzootic mosquitoes Haemagogus leucocelaenus and Sabethes albiprivus are highly susceptible to YFV [10]. </plain></SENT>
<SENT sid="82555" pm="."><plain>Thus, the widely distributed Ae. aegypti in American countries raises the concern of a re-urbanization of YF if the virus is introduced via viremic vertebrate hosts. </plain></SENT>
<SENT sid="82556" pm="."><plain>In the Caribbean, Guadeloupe Island has experienced several outbreaks caused by arboviruses such as dengue [11], chikungunya [12] and zika [13], all three viruses only be transmitted by Ae. aegypti as Ae. albopictus is absent from the island [14]. </plain></SENT>
<SENT sid="82557" pm="."><plain>To be considered as an epidemic vector of YFV, Ae. aegypti should be experimentally susceptible to the virus (i.e. a competent vector) in addition of being an anthropophilic mosquito [15] in close contacts with humans [16]. </plain></SENT>
<SENT sid="82558" pm="."><plain>In this report, we evaluate the vector competence of Ae. aegypti from Guadeloupe to YFV. </plain></SENT>
<SENT sid="82559" pm="."><plain>These results will help the local health authorities and the decision-makers to anticipate the arrival of YF in the Caribbean. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="sec002"><title><text><SENT sid="82560" pm="."><plain>Materials and methods </plain></SENT>
</text></title><sec id="sec003"><title><text><SENT sid="82561" pm="."><plain>Virus strain </plain></SENT>
</text></title><p><text><SENT sid="82562" pm="."><plain>The strain IEC-4408 (YFV-4408; accession number: KY861728) belonging to the 1E lineage of YFV, was isolated from a Howler monkey in 2008 [10]. </plain></SENT>
<SENT sid="82563" pm="."><plain>The strain was passaged four times on Ae. albopictus C6/36 cells. </plain></SENT>
<SENT sid="82564" pm="."><plain>Viral stocks for mosquito infections were produced on C6/36 cells and stored at -80°C. </plain></SENT>
</text></p></sec><sec id="sec004"><title><text><SENT sid="82565" pm="."><plain>Artificial blood feeding </plain></SENT>
</text></title><p><text><SENT sid="82566" pm="."><plain>Six boxes of 60 7-day-old F1 female adults (F0 collected as larvae in June 2017 in Deshaies, Basse Terre, Guadeloupe) were fed on an infectious blood meal containing 1.4 mL of washed rabbit red blood cells and 0.7 mL of virus suspension. </plain></SENT>
<SENT sid="82567" pm="."><plain>The blood meal supplemented with ATP as a phagostimulant at a final concentration of 1 mM was provided to mosquitoes at a titer of 106.5 focus-forming unit (ffu)/mL using a Hemotek membrane feeding system. </plain></SENT>
<SENT sid="82568" pm="."><plain>Engorged mosquitoes were transferred into boxes and maintained with 10% sucrose at 28°C under a photoperiod of 12:12. </plain></SENT>
</text></p></sec><sec id="sec005"><title><text><SENT sid="82569" pm="."><plain>Mosquito sampling and processing </plain></SENT>
</text></title><p><text><SENT sid="82570" pm="."><plain>Mosquitoes were examined at 7, 14, and 21 days post-infection (dpi). </plain></SENT>
<SENT sid="82571" pm="."><plain>After removing mosquito wings and legs, the proboscis was inserted into a P20 tip filled with 5 μL of fetal bovine serum (FBS) [17]. </plain></SENT>
<SENT sid="82572" pm="."><plain>After 30 min, saliva was expelled from the tip to 45 μL of L-15 medium (Invitrogen, California, USA) and then processed for viral titration to estimate transmission. </plain></SENT>
<SENT sid="82573" pm="."><plain>Then, mosquito head and body were collected and ground individually in 300 μL of L-15 medium supplemented with 2% FBS, for respectively, viral infection and dissemination analysis. </plain></SENT>
<SENT sid="82574" pm="."><plain>200 μL of homogenates were collected after centrifugation at 10,000 g for 5 min at +4°C before viral titration. </plain></SENT>
<SENT sid="82575" pm="."><plain>To estimate the vector competence, three parameters were calculated: (i) infection rate (IR) referring to the proportion of mosquitoes with infected body among engorged mosquitoes, (ii) dissemination rate (DR) corresponding to the proportion of mosquitoes with infected head among mosquitoes with infected body, and (iii) transmission rate (TR) representing the proportion of mosquitoes with infectious saliva among mosquitoes with infected head. </plain></SENT>
</text></p></sec><sec id="sec006"><title><text><SENT sid="82576" pm="."><plain>Virus titration </plain></SENT>
</text></title><p><text><SENT sid="82577" pm="."><plain>Mosquito samples were titrated by focus fluorescent assay on Ae. albopictus C6/36 cells in 96-well plates [18]. </plain></SENT>
<SENT sid="82578" pm="."><plain>After 5 days of incubation at 28°C, plates were stained using antibodies specific to YFV as the primary antibody and conjugated Alexa Fluor 488 goat anti-mouse IgG as the second antibody (Life Technologies, California, USA). </plain></SENT>
</text></p></sec><sec id="sec007"><title><text><SENT sid="82579" pm="."><plain>Statistical analysis </plain></SENT>
</text></title><p><text><SENT sid="82580" pm="."><plain>Statistical analyses were performed with Stata software (StataCorp LP, Texas, and USA). </plain></SENT>
<SENT sid="82581" pm="."><plain>P-values&lt;0.05 were considered significant. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec sec-type="results" id="sec008"><title><text><SENT sid="82582" pm="."><plain>Results </plain></SENT>
</text></title><p><text><SENT sid="82583" pm="."><plain>Mosquitoes were analyzed at three time points following infection: 7, 14 and 21 days post infection (dpi). </plain></SENT>
<SENT sid="82584" pm="."><plain>At 7 dpi, 56.7% (17/30) of mosquitoes examined had infected bodies (Fig 1). </plain></SENT>
<SENT sid="82585" pm="."><plain>Among them, 29.4% (5/17) of mosquitoes were able to ensure a viral dissemination beyond the midgut barrier in the hemocele. </plain></SENT>
<SENT sid="82586" pm="."><plain>No mosquitoes were able to transmit the virus with no viral particles detected in mosquito saliva. </plain></SENT>
<SENT sid="82587" pm="."><plain>Later, at 14 dpi, a higher proportion, 70% (21/30) of mosquitoes had an infected body and among them, 57.1% (12/21) presented a positive viral dissemination into the hemocele. </plain></SENT>
<SENT sid="82588" pm="."><plain>Then, 8.3% (1/12) had virus in saliva, indicative of viral transmission; one mosquito had 20 viral particles. </plain></SENT>
<SENT sid="82589" pm="."><plain>At 21 dpi, the proportion of mosquitoes with infected body decreased to 50% (15/30) and among them, more than half (53.3%; 8/15) could ensure a viral dissemination. </plain></SENT>
<SENT sid="82590" pm="."><plain>A slightly higher proportion of mosquitoes (12.5%; 1/8) with disseminated infection presented virus in saliva; one mosquito had 200 viral particles. </plain></SENT>
<SENT sid="82591" pm="."><plain>Rates did not significantly vary according to dpi: 7 dpi (Chi-square test: χ2 = 2.57, df = 2, p = 0.27), 14 dpi (Chi-square test: χ2 = 3.21, df = 2, p = 0.20), and 21 dpi (Chi-square test: χ2 = 0.65, df = 2, p = 0.72). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone.0204710.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0204710.g001</object-id><label>Fig 1</label><caption><title><text><SENT sid="82592" pm="."><plain>Infection, dissemination and transmission rates of Aedes aegypti guadeloupe to YFV (IEC-4408, 1E lineage). </plain></SENT>
</text></title><p><text><SENT sid="82593" pm="."><plain>Mosquitoes were exposed to an infectious blood meal with YFV provided at a titer of 106.5 ffu/mL. </plain></SENT>
<SENT sid="82594" pm="."><plain>After infection, mosquitoes were examined at 7, 14, and 21 days post-infection. </plain></SENT>
<SENT sid="82595" pm="."><plain>Error bars show the 95% confidence interval. </plain></SENT>
<SENT sid="82596" pm="."><plain>In brackets, the number of mosquitoes examined. </plain></SENT>
<SENT sid="82597" pm="."><plain>IR: the proportion of mosquitoes with infected body among engorged mosquitoes; DR: the proportion of mosquitoes with infected head among mosquitoes with infected body; TR: the proportion of mosquitoes with infectious saliva among mosquitoes with infected head. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0204710.g001"/></fig></SecTag></sec></SecTag><SecTag type="DISCUSS"><sec sec-type="conclusions" id="sec009"><title><text><SENT sid="82598" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="82599" pm="."><plain>Except Trinidad and Tobago in 1979 [19], the Caribbean has not suffered from YF since 1960. </plain></SENT>
<SENT sid="82600" pm="."><plain>The ongoing YFV circulation in Brazil raises concern regarding viral importation into the Caribbean. </plain></SENT>
<SENT sid="82601" pm="."><plain>However, the requirement of YF vaccination is not mandatory in many Caribbean islands (e.g. Haiti, Cuba), but restricted to the travelers coming from YF-epidemic countries (<ext-link ext-link-type="uri" xlink:href="http://www.who.int/ith/ITH_country_list.pdf?ua=1">http://www.who.int/ith/ITH_country_list.pdf?ua=1</ext-link>). </plain></SENT>
<SENT sid="82602" pm="."><plain>The disease control relies only on the check of vaccination card, which is insufficient for YF prevention. </plain></SENT>
<SENT sid="82603" pm="."><plain>Thus, YF is still a threat for this region where Ae. aegypti is widely distributed. </plain></SENT>
<SENT sid="82604" pm="."><plain>Here, although not based on vertebrate animal transmission model, we demonstrated that Ae. aegypti from Guadeloupe are susceptible to YFV and able to transmit viral particles from 14 days post-infection. </plain></SENT>
</text></p><p><text><SENT sid="82605" pm="."><plain>Viral infection, dissemination and transmission increased along with dpi. </plain></SENT>
<SENT sid="82606" pm="."><plain>Infection and dissemination reached a peak at 14 dpi (70% and 57% for IR and DR, respectively), suggesting that the midgut has a limited role as barrier to the viral dissemination in the mosquito general cavity. </plain></SENT>
<SENT sid="82607" pm="."><plain>Transmission was only detected from 14 dpi suggesting an extrinsic incubation period (i.e. period between the ingestion of infectious blood meal and the excretion of virus in saliva) is between 7 and 14 days as shown for Ae. aegypti populations from Congo and Brazil [10]. </plain></SENT>
<SENT sid="82608" pm="."><plain>However transmission was quite low (i.e. 8%) suggesting a significant role of salivary glands to retain viral particles. </plain></SENT>
<SENT sid="82609" pm="."><plain>At 21 days post-infection, transmission was more efficient with 12% of mosquitoes presenting disseminated infection and delivering virus in saliva. </plain></SENT>
</text></p><p><text><SENT sid="82610" pm="."><plain>It is now widely admitted that vector competence depends on the virus genotype, the mosquito genotype and their interactions, promoting local adaptation of viral lineages to mosquito vector populations [20]. </plain></SENT>
<SENT sid="82611" pm="."><plain>The table below (Table 1) presents the vector competence of several Ae. aegypti populations from Africa, America, Asia and South Pacific region to several lineages/genotypes of YFV, exemplifying the specific outcome to each combination virus-vector. </plain></SENT>
</text></p><SecTag type="TABLE"></SecTag><p><text><SENT sid="83071" pm="."><plain>The pattern of Ae. aegypti Guadeloupe infected with a YFV belonging to the 1E lineage (IEC-4408; [10]) should be close to the profile of mosquitoes from the American continent. Ae. aegypti from Rio and Manaus presented similar IR, DR and TR when compared to Ae. aegypti Guadeloupe (see Table 1, [10]). </plain></SENT>
<SENT sid="83072" pm="."><plain>It has been demonstrated previously that Ae. aegypti from the Caribbean were genetically close to mosquitoes from Brazil [27]. </plain></SENT>
<SENT sid="83073" pm="."><plain>However, other factors should be considered to assess the risk of transmission; while YF is still absent from Asia, the vector competence of Asian Ae. aegypti (see Table 1; Phnom Penh: DR = 64%, Ho Chi Minh city: DR = 48%) was higher than values of Ae. aegypti from Africa. </plain></SENT>
<SENT sid="83074" pm="."><plain>These factors include: vector densities, trophic preference of vectors for humans, proportion of immunologically naïve humans, and environmental conditions favorable to transmission. </plain></SENT>
<SENT sid="83075" pm="."><plain>Surveillance of travelers coming from YFV-endemic regions of Africa or South America able to initiate a local transmission in the Caribbean should be reinforced. </plain></SENT>
<SENT sid="83076" pm="."><plain>Likewise, vaccination coverage should be reexamined as the live-attenuated 17D is one of the most effective vaccines available against this arbovirus. </plain></SENT>
</text></p></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="83077" pm="."><plain>We thank Laurence Mousson and Marie Vazeille for technical help, Cédric Ramdini and Joel Gustave for their support during mosquito sampling campaigns, and Pedro Fernando da Costa Vasconselos for providing the viral strain. </plain></SENT>
<SENT sid="83078" pm="."><plain>P-S.Y. was supported by the Institut Pasteur and the National Health Research Institutes in Taiwan. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0204710.ref001"><text><SENT sid="83079" pm="."><plain>1MonathTP, VasconcelosPF. Yellow fever. Journal of clinical virology: the official publication of the Pan American Society for Clinical Virology. 2015;64:160–73. 10.1016/j.jcv.2014.08.030 .<?supplied-pmid 25453327?>25453327 </plain></SENT>
</text></ref><ref id="pone.0204710.ref002"><text><SENT sid="83080" pm="."><plain>2VasconcelosPF. Yellow fever in Brazil: thoughts and hypotheses on the emergence in previously free areas. Rev Saude Publica. 2010;44(6):1144–9. .<?supplied-pmid 21109907?>21109907 </plain></SENT>
</text></ref><ref id="pone.0204710.ref003"><text><SENT sid="83081" pm="."><plain>3PAHO. </plain></SENT>
<SENT sid="83082" pm="."><plain>Epidemiological Update: Yellow Fever. </plain></SENT>
<SENT sid="83083" pm="."><plain>20 March 2018. </plain></SENT>
<SENT sid="83084" pm="."><plain>Washington, D.C.: 2018. </plain></SENT>
</text></ref><ref id="pone.0204710.ref004"><text><SENT sid="83085" pm="."><plain>4BryanCS, MossSW, KahnRJ. Yellow fever in the Americas. Infect Dis Clin North Am. 2004;18(2):275–92, table of contents. </plain></SENT>
<SENT sid="83086" pm="."><plain>Epub 2004/05/18. 10.1016/j.idc.2004.01.007 .<?supplied-pmid 15145381?>15145381 </plain></SENT>
</text></ref><ref id="pone.0204710.ref005"><text><SENT sid="83087" pm="."><plain>5GoodyearJD. The sugar connection: a new perspective on the history of yellow fever. Bull Hist Med. 1978;52(1):5–21. </plain></SENT>
<SENT sid="83088" pm="."><plain>Epub 1978/01/01. .<?supplied-pmid 352452?>352452 </plain></SENT>
</text></ref><ref id="pone.0204710.ref006"><text><SENT sid="83089" pm="."><plain>6CatheyJT, MarrJS. Yellow fever, Asia and the East African slave trade. Trans R Soc Trop Med Hyg. 2014;108(5):252–7. </plain></SENT>
<SENT sid="83090" pm="."><plain>Epub 2014/04/20. 10.1093/trstmh/tru043 .<?supplied-pmid 24743951?>24743951 </plain></SENT>
</text></ref><ref id="pone.0204710.ref007"><text><SENT sid="83091" pm="."><plain>7PAHO. The feasibility of eradicating Aedes aegypti in the Americas. Rev Panam Salud Publica. 1997;1(1):68–72. </plain></SENT>
<SENT sid="83092" pm="."><plain>Epub 1997/01/01. .<?supplied-pmid 9128110?>9128110 </plain></SENT>
</text></ref><ref id="pone.0204710.ref008"><text><SENT sid="83093" pm="."><plain>8VasconcelosPFC, RosaAPAT, PinheirofP, RodriguesSG, S.T.RE, CruzACR, et al Aedes aegypti, Dengue and Re-urbanization of Yellow Fever in Brazil and other South American Countries—Past and Present Situation and Future Perspectives. Dengue Bulletin. 1999;23:11. </plain></SENT>
</text></ref><ref id="pone.0204710.ref009"><text><SENT sid="83094" pm="."><plain>9BarrettAD, HiggsS. Yellow fever: a disease that has yet to be conquered. Annu Rev Entomol. 2007;52:209–29. 10.1146/annurev.ento.52.110405.091454 .<?supplied-pmid 16913829?>16913829 </plain></SENT>
</text></ref><ref id="pone.0204710.ref010"><text><SENT sid="83095" pm="."><plain>10Couto-LimaD, MadecY, BersotMI, CamposSS, MottaMA, SantosFBD, et al Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations. Sci Rep. 2017;7(1):4848 10.1038/s41598-017-05186-3 .<?supplied-pmid 28687779?>28687779 </plain></SENT>
</text></ref><ref id="pone.0204710.ref011"><text><SENT sid="83096" pm="."><plain>11LarrieuS, CassadouS, RosineJ, ChappertJL, BlateauA, LedransM, et al Lessons raised by the major 2010 dengue epidemics in the French West Indies. Acta Trop. 2014;131:37–40. </plain></SENT>
<SENT sid="83097" pm="."><plain>Epub 2013/12/10. 10.1016/j.actatropica.2013.11.023 .<?supplied-pmid 24315801?>24315801 </plain></SENT>
</text></ref><ref id="pone.0204710.ref012"><text><SENT sid="83098" pm="."><plain>12DorleansF, HoenB, NajioullahF, Herrmann-StorckC, SchepersKM, AbelS, et al Outbreak of Chikungunya in the French Caribbean Islands of Martinique and Guadeloupe: Findings from a Hospital-Based Surveillance System (2013–2015). Am J Trop Med Hyg. 2018;98(6):1819–25. </plain></SENT>
<SENT sid="83099" pm="."><plain>Epub 2018/04/26. 10.4269/ajtmh.16-0719 .<?supplied-pmid 29692295?>29692295 </plain></SENT>
</text></ref><ref id="pone.0204710.ref013"><text><SENT sid="83100" pm="."><plain>13Daudens-VaysseE, LedransM, GayN, ArdillonV, CassadouS, NajioullahF, et al Zika emergence in the French Territories of America and description of first confirmed cases of Zika virus infection on Martinique, November 2015 to February 2016. Euro Surveill. 2016;21(28). </plain></SENT>
<SENT sid="83101" pm="."><plain>Epub 2016/07/23. 10.2807/1560-7917.ES.2016.21.28.30285 .<?supplied-pmid 27447300?>27447300 </plain></SENT>
</text></ref><ref id="pone.0204710.ref014"><text><SENT sid="83102" pm="."><plain>14GustaveJ. </plain></SENT>
<SENT sid="83103" pm="."><plain>[The prevention of dengue in Guadeloupe]. Bull Soc Pathol Exot. 1996;89(2):143–4. </plain></SENT>
<SENT sid="83104" pm="."><plain>Epub 1996/01/01. .<?supplied-pmid 8924773?>8924773 </plain></SENT>
</text></ref><ref id="pone.0204710.ref015"><text><SENT sid="83105" pm="."><plain>15GoindinD, DelannayC, GelasseA, RamdiniC, GaudeT, FauconF, et al Levels of insecticide resistance to deltamethrin, malathion, and temephos, and associated mechanisms in Aedes aegypti mosquitoes from the Guadeloupe and Saint Martin islands (French West Indies). Infect Dis Poverty. 2017;6(1):38 Epub 2017/02/12. 10.1186/s40249-017-0254-x ; PubMed Central PMCID: PMCPMC5303256.<?supplied-pmid 28187780?>28187780 </plain></SENT>
</text></ref><ref id="pone.0204710.ref016"><text><SENT sid="83106" pm="."><plain>16GustaveJ, FouqueF, CassadouS, LeonL, AnicetG, RamdiniC, et al Increasing Role of Roof Gutters as Aedes aegypti (Diptera: Culicidae) Breeding Sites in Guadeloupe (French West Indies) and Consequences on Dengue Transmission and Vector Control. J Trop Med. 2012;2012:249524 Epub 2012/05/02. 10.1155/2012/249524 ; PubMed Central PMCID: PMCPMC3323855.<?supplied-pmid 22548085?>22548085 </plain></SENT>
</text></ref><ref id="pone.0204710.ref017"><text><SENT sid="83107" pm="."><plain>17DubrulleM, MoussonL, MoutaillerS, VazeilleM, FaillouxAB. Chikungunya virus and Aedes mosquitoes: saliva is infectious as soon as two days after oral infection. PLoS One. 2009;4(6):e5895 10.1371/journal.pone.0005895 ; PubMed Central PMCID: PMC2690823.<?supplied-pmid 19521520?>19521520 </plain></SENT>
</text></ref><ref id="pone.0204710.ref018"><text><SENT sid="83108" pm="."><plain>18PayneAF, Binduga-GajewskaI, KauffmanEB, KramerLD. Quantitation of flaviviruses by fluorescent focus assay. J Virol Methods. 2006;134(1–2):183–9. 10.1016/j.jviromet.2006.01.003 .<?supplied-pmid 16510196?>16510196 </plain></SENT>
</text></ref><ref id="pone.0204710.ref019"><text><SENT sid="83109" pm="."><plain>19PastorinoBA, PeyrefitteCN, AlmerasL, GrandadamM, RollandD, TolouHJ, et al Expression and biochemical characterization of nsP2 cysteine protease of Chikungunya virus. Virus Res. 2008;131(2):293–8. 10.1016/j.virusres.2007.09.009 .<?supplied-pmid 17961784?>17961784 </plain></SENT>
</text></ref><ref id="pone.0204710.ref020"><text><SENT sid="83110" pm="."><plain>20LambrechtsL, ScottTW, GublerDJ. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis. 2010;4(5):e646 10.1371/journal.pntd.0000646 ; PubMed Central PMCID: PMC2876112.<?supplied-pmid 20520794?>20520794 </plain></SENT>
</text></ref><ref id="pone.0204710.ref021"><text><SENT sid="83111" pm="."><plain>21EllisBR, SangRC, HorneKM, HiggsS, WessonDM. Yellow fever virus susceptibility of two mosquito vectors from Kenya, East Africa. Trans R Soc Trop Med Hyg. 2012;106(6):387–9. </plain></SENT>
<SENT sid="83112" pm="."><plain>Epub 2012/04/24. 10.1016/j.trstmh.2012.02.007 .<?supplied-pmid 22521217?>22521217 </plain></SENT>
</text></ref><ref id="pone.0204710.ref022"><text><SENT sid="83113" pm="."><plain>22JuppPG, KempA. Laboratory vector competence experiments with yellow fever virus and five South African mosquito species including Aedes aegypti. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2002;96(5):493–8. .<?supplied-pmid 12474475?>12474475 </plain></SENT>
</text></ref><ref id="pone.0204710.ref023"><text><SENT sid="83114" pm="."><plain>23VazeilleM, YebakimaA, Lourenco-de-OliveiraR, AndriamahefazafyB, CorreiraA, RodriguesJM, et al Oral receptivity of Aedes aegypti from Cape Verde for yellow fever, dengue, and chikungunya viruses. Vector Borne Zoonotic Dis. 2013;13(1):37–40. 10.1089/vbz.2012.0982 .<?supplied-pmid 23199267?>23199267 </plain></SENT>
</text></ref><ref id="pone.0204710.ref024"><text><SENT sid="83115" pm="."><plain>24Lourenco-de-OliveiraR, VazeilleM, Bispo de FilippisAM, FaillouxAB. Oral susceptibility to yellow fever virus of Aedes aegypti from Brazil. Mem Inst Oswaldo Cruz. 2002;97(3):437–9. .<?supplied-pmid 12048581?>12048581 </plain></SENT>
</text></ref><ref id="pone.0204710.ref025"><text><SENT sid="83116" pm="."><plain>25JohnsonBW, ChambersTV, CrabtreeMB, FilippisAM, VilarinhosPT, ResendeMC, et al Vector competence of Brazilian Aedes aegypti and Ae. albopictus for a Brazilian yellow fever virus isolate. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2002;96(6):611–3. .<?supplied-pmid 12625133?>12625133 </plain></SENT>
</text></ref><ref id="pone.0204710.ref026"><text><SENT sid="83117" pm="."><plain>26van den HurkAF, McElroyK, PykeAT, McGeeCE, Hall-MendelinS, DayA, et al Vector competence of Australian mosquitoes for yellow fever virus. The American journal of tropical medicine and hygiene. 2011;85(3):446–51. 10.4269/ajtmh.2011.11-0061 ; PubMed Central PMCID: PMC3163864.<?supplied-pmid 21896802?>21896802 </plain></SENT>
</text></ref><ref id="pone.0204710.ref027"><text><SENT sid="83118" pm="."><plain>27MoussonL, DaugaC, GarriguesT, SchaffnerF, VazeilleM, FaillouxAB. Phylogeography of Aedes (Stegomyia) aegypti (L.) and Aedes (Stegomyia) albopictus (Skuse) (Diptera: Culicidae) based on mitochondrial DNA variations. Genetical research. 2005;86(1):1–11. 10.1017/S0016672305007627 .<?supplied-pmid 16181519?>16181519 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
